Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients

americanpharmaceuticalreviewAugust 12, 2020

Tag: Pacira BioSciences , FDA , Exparel

PharmaSources Customer Service